Manufacturing

Spray Drying Enables Inhalation Drug Delivery

Formulation and manufacturing process parameters affect particle performance.

Prefilled Syringe Innovations

New container and equipment designs expand applications.

Cleaning Continuous Manufacturing Equipment

Consider best practices for manual or clean-in-place procedures.

Pfizer and Arvinas to Develop and Commercialize Estrogen Receptor Targeting Breast Cancer

July 22, 2021

The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.

Summa Equity Acquires Cleanroom Provider G-CON Manufacturing

July 22, 2021

Summa Equity has acquired a majority stake in G-CON Manufacturing, a prefabricated cleanroom provider.

Catalent Biologics Launches New Cell Line Expression Technology

July 22, 2021

Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.

Catalent Invests $100 Million to Expand European Biologics Manufacturing Capabilities

July 22, 2021

Catalent commences the first phase of a $100-million expansion program Anagni site to increase its manufacturing capabilities for biologics drug substance.

Samsung Biologics Partners with Kineta for Anti-VISTA Antibody Immunotherapy

July 21, 2021

Samsung Biologics and Kineta have entered into a strategic partnership for drug product manufacturing services and to support an IND filing of a novel antibody therapeutic.

BioNTech to Acquire Kite’s TCR Cell Therapy Platform and Manufacturing Facility

July 21, 2021

BioNTech will acquire a TCR cell therapy R&D platform as well as a manufacturing facility in Gaithersburg, Md., from Kite, a Gilead company.

Nkarta Establishes New NK Cell Therapy Manufacturing Facility and Headquarters

July 21, 2021

Nkarta will establish a new combined scalable NK cell therapy manufacturing facility and corporate headquarters in South San Francisco, Calif.

Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy Manufacturing

July 21, 2021

Cellares has entered into a strategic relationship with Poseida Therapeutics to advance a closed, automated, and scalable cell therapy manufacturing system.

Pall Enters Multi-Million Dollar Contract with Exothera for Viral Vector Manufacturing

July 21, 2021

Pall has secured a manufacturing contract with Exothera for the suspension-based manufacture of gene therapies and viral vector-based vaccines.

Cold-Chain Shippers: One-Trip vs. Multiple Trips

July 19, 2021

Manufacturers seek more sustainable options for temperature-controlled packaging.